• 沒有找到結果。

鑑定新穎微小核醣核酸生合成及功能之調控因子

N/A
N/A
Protected

Academic year: 2022

Share "鑑定新穎微小核醣核酸生合成及功能之調控因子"

Copied!
210
0
0

加載中.... (立即查看全文)

全文

(1)

Graduate Institute of Microbiology College of Medicine

National Taiwan University Doctoral Dissertation

To identify novel modulators of miRNA biogenesis and function

Yu-De Chu

Advisor: Shih-Peng Chan, Ph.D.

105 7

July 2016

(2)

(tB) tlt±^^C

^AH^: ^^^a^gt^S^^^L^

^-^t^a^

^A^§: To identify novel modulators of miRNA biogenesis and function

-Af-rVB

^t^ ^f^ ^ (^^ F99445120 ) i£^^S^^-^^^

^-^^T^^^I (t^) ±-^^i^, ^a 105 ^ 7 ^ 12 B7?<T

N^g^M^^?SM^n^X^, ^ittH^

n^^^: ^ ^

(^^)

A^

? ^

A

^/

yA^

J^f. ^f

^^ ^rcm ^ ^ <^)

(3)

(4)

(miRNA) 70%

(RNAi) DEAD/H-box

let-7(mg279) DDX-23

DDX-17 let-7 (phenotype)

let-7

let-7 let-7 (primary-let-7)

let-7

(primary miRNA)

let-7 heterochronic lin-4 miR-48 miR-84

miR-241

heterochronic lsy-6 DDX-23 DDX-17

DDX-23 DDX-17

hnRNP hnRNP Q HRP-2 let-7(n2853)

(5)

HRP-2 (miRISC)

lin-41 3’UTR let-7

poly-A HRP-2 lin-41

HRP-2

HRP-2 3’UTR

let-7 lin-41

HRP-2 let-7 lin-41

hnRNP Q let-7 lin-41

TRIM71 HRP-2 lin-41

3’UTR TRIM71 3’UTR

hnRNP Q let-7

poly-A 3’UTR let-7

TRIM71 HRP-2

hnRNP Q lin-41

TRIM71 3’UTR let-7

let-7 DDX-23 HRP-2 hnRNP Q lin-41/TRIM71

(6)

Abstract

As post-transcriptionally gene regulators demonstrated by numerous studies, microRNAs have been predicted to control more than 70% of human coding genes expression. However, studies regarding modulators for miRNA biogenesis and/or function remain relatively few. Here, we performed a candidate-based RNAi screen in C. elegans to identify DEAD/H-box proteins involved in miRNA biogenesis and/or function. In the let-7(mg279) sensitized genetic background, knockdown of a homolog of yeast splicing factor Prp28p, DDX-23, or a homolog of human helicases p68 and p72, DDX-17, enhanced let-7 loss-of-function phenotypes, suggesting that these helicases play a role in let-7 processing and/or function. In both ddx-23(RNAi) and ddx-17(RNAi), levels of mature let-7 were decreased while pri-let-7 was found accumulated, indicating that the helicases likely act at the level of pri-let-7 processing. DDX-23 and DDX-17 were also required for the biogenesis of other known heterochronic miRNAs, including lin-4 and the let-7 family members miR-48, miR-84 and miR-241. Their function was not confined to the heterochronic pathway, however, since they were both necessary for down-regulation of cog-1 by the spatial patterning miRNA, lsy-6. Therefore, we present a novel function for C. elegans DDX-23 in pri-miRNA processing, and also suggest a conserved role for DDX-17 in this process. On the other hand, we also show that RNAi knockdown of C. elegans HRP-2, the homolog of mammalian hnRNP Q, relieved the heterochronic phenotypes in let-7(n2853) mutant animals, indicating an involvement of HRP-2 in let-7-lin-41 regulation. In addition, we detected an RNA-dependent

(7)

miRNA-mediated silencing complex (miRISC). Moreover, we identified an HRP-2 response element in the lin-41 3’UTR at a position, downstream of the two let-7 complementary sites (LCSs), close to the poly(A)-tail. Deletion of this response element caused further down regulation of a GFP reporter carrying the lin-41 3’UTR in a let-7-dependent manner. Thus, we propose that HRP-2 impedes let-7/miRISC activity when binding to the lin-41 3’UTR. Interestingly, we found that depletion of human hnRNP Q also enhanced let-7-mediated down-regulation of TRIM71. Similar to the case in C. elegans, hnRNP Q binds to a response element adjacent to the poly(A)-tail in the TRIM71 3’UTR. Deleting this element from the 3’UTR significantly enhanced let-7 repression. Taken together, our findings uncover a novel evolutionarily conserved function for HRP-2/hnRNP Q to inhibit let-7/miRISC activity when they bind to specific response elements in the lin-41/TRIM71 3’UTRs.

Key words: miRNA, let-7, DDX-23, biogenesis, HRP-2, hnRNP Q, lin-41/TRIM71

(8)

………I

………..II

……….III

English abstract……….V

………...1

Chapter 1 Introduction ………11

1.1 microRNAs……….11

1.1.1 Discovery of miRNAs……….11

1.1.2 miRNA family………...12

1.1.3 Functions of miRNAs……….13

1.1.4 Biogenesis of miRNAs………14

1.2 The let-7 miRNA………14

1.2.1 Regulation of let-7 biosynthesis………..14

(9)

1.2.3 The evolutionary conserved let-7/lin-41 regulatory pathway……….17

1.3 The DExD/H-box RNA helicases ………..18

1.3.1 Functions of the DExD/H-box RNA helicases………...18

1.3.2 The implication of DExD/H-box RNA helicases in the miRNA

pathway……….……..19

1.4 Heterogeneous nuclear proteins (hnRNPs) ……….….…..20

1.4.1 Functions of hnRNPs………..20

1.4.2 The potential roles of hnRNPs in the miRNA pathway………….….21

1.5 The animal model—Caenorhabditis elegans……….…22

1.5.1 The advantages of using C. elegnas as animal model……….…22

1.5.2 The heterochronic gene pathway and let-7 miRNA in C. elegans…..22

1.5.3 Controlling of vulval development by miR-84-mediated repression of

let-60/RAS……….……..24

1.5.4 The lsy-6 miRNA-mediated repression of cog-1…….….…………..25

1.6 Project aims……….26

Chapter 2 Materials and Methods………...27

2. 1 Caenorhabditis elegans……….….….……….27

(10)

2.1.1 Strains………….….….……….27

2.1.2 Culture………...28

2.1.3 RNA-interference (RNAi) ………....28

2.2 Construction of plasmids………...30

2.2.1 C. elegans RNAi clones……….………...30

2.2.2 C. elegans expressing plasmids……….………...30

2.2.3 TRIM71 3’UTR fused luciferase plasmids…….………...32

2.2.4 hnRNP Q1 plasmids……….………...32

2.2.5 Ago2-GFP plasmid……….………...33

2.3 Microscopy analysis……….………...34

2.4 RNA isolation……….………...34

2.4.1 From C. elegans……….………...34

2.4.2 From human cell cultures………….……...35

2.5 Northern blot analysis………...35

2.6 RT-PCR and RT-qPCR…………...37

2.6.1 Poly-A tail-based reverse transcription and qPCR...37

(11)

2.7 Lysate preparation…………...45

2.7.1 For C. elegans western blot analysis………...45

2.7.2 For C. elegans immunoprecipitation experiment………...46

2.7.3 For mammalian cell lines western blot analysis………...46

2.7.4 For mammalian cell lines immunoprecipitation experiment………...47

2.8 Western blot analysis………....………...47

2.9 Co-immunoprecipitation……….….….……...48

2.10 RNA-immunoprecipitation (RIP)……….….….……...49

2.11 In vitro transcription………...50

2.12 Biotinylated RNA affinity selection pull-down……….………….…...54

2.13 Generation of transgenic C. elegans……….………….…...55

2.13.1 Conventional microinjection……….………….…...55

2.13.2 Mos1 mediated single copy transgene insertion (MosSCI)...55

2.14 Integration of extra-chromosomal array in C. elegans...56

2.15 Cell culture and transfection……….………….…...57

2.16 Lenti-virus infection……….………….…...58

2.17 Luciferase assay……….………….…...60

(12)

2.18 DAPI staining……….………….…...61

Chapter 3 Results……….………….…...63

3.1 The role of DDX-23 in primary microRNA processing in Caenorhabditis elegans……….………….…...63

3.1.1 The potential roles for several DEAD-box RNA helicases in let-7-mediated gene regulation……….…...63

3.1.2 DDX-23 and DDX-17 promote let-7 maturation...67

3.1.3 DDX-23 and DDX-17 support the processing of primary let-7...67

3.1.4 DDX-23 and DDX-17 facilitate regulation of let-60/RAS by miR-84...68

3.1.5 DDX-23 and DDX-17 support pri-miR-84 biogenesis...70

3.1.6 DDX-23 and DDX-17 are also required for other heterochronic miRNAs processing...…...71

3.1.7 Expression of miRNA pathway components is not affected by depletion of DDX-23 or DDX-17...…...71

3.1.8 DDX-23 is localized to the nucleus and functions with miRNAs in multiple tissues...…...73

(13)

3.2 HRP-2/hnRNP Q impede let-7-mediated repression of lin-41/TRIM71 in

Caenorhabditis. elegans and humans...75

3.2.1 HRP-2 functions upstream of lin-29...75

3.2.2 Depletion of HRP-2 causes precocious lin-29 expression...77

3.2.3 Depletion of HRP-2 enhances let-7-mediated repression of lin-41...78

3.2.4 Depletion of HRP-2 does not alter let-7 level...79

3.2.5 C. elegans HRP-2 interacts with ALG-1 in an RNA-dependent manner...80

3.2.6 HRP-2 directly interacts with lin-41 3’UTR...80

3.2.7 HRP-2 binds to lin-41 3’UTR at a position between LCS and poly-(A)…..81

3.2.8 Deletion of HRE enhances let-7-mediated repression of lin-41...84

3.2.9 HRP-2 locates in both nucleus and cytoplasmic fractions...85

3.2.10 hnRNP R does not involved in let-7-mediated repression of TRIM71...87

3.2.11 hnRNP Q blocks repression of TRIM71 by let-7...88

3.2.12 hnRNP Q is associated with miRISCs...90

3.2.13 hnRNP Q binds to an element at a position near poly-A tail in TRIM71 3’UTR...92

3.2.14 QRE in TRIM71 3’UTR is required for hnRNP Q binding...93

(14)

3.2.15 Deletion of QRE enhances let-7-mediated repression of TRIM71...94

Chapter 4 Discussion...96

4.1 A novel function for the DEAD-box RNA helicase DDX-23 in primary miRNA

processing in C. elegans...96

4.2 HRP-2/hnRNP Q impedes let-7 miRNA-mediated repression of lin-41/TRIM71 in

C. elegans and humans...102

Chapter 5 Table...108

Table 1. Using let-7(n2853) mutant to screen for hnRNP(s) involved in let-7/lin-41

pathway...108

Chapter 6 Figures...109

Figure 1. The vulval bursting phenotype caused by RNAi knockdown of DEAD-box

RNA helicase genes...109

Figure 2. The retarded seam cell development caused by RNAi knockdown of

several DEAD-box helicases...111

Figure 3. Depletion of DDX-17 or MOG-4 causes discontinued clusters of seam

(15)

Figure 4. Adult hermaphrodites show disrupted seam cell syncytia or unfused seam

cells upon RNAi against several RNA helicase genes...113

Figure 5. col-19::GFP expression is down-regulated upon RNAi against several

RNA helicase genes...115

Figure 6. RNAi knockdown of ddx-23, ddx-17 and mog-4 reduced mature let-7

levels...117

Figure 7. DDX-23 and DDX-17 are required for pri-let-7 processing……….118

Figure 8. Inactivation of ddx-23 and ddx-17 enhance the MUV phenotype in let-60

gain-of-function mutant...120

Figure 9. Reduced expression of ddx-23 and ddx-17 increases accumulation of

pri-miR-84...122

Figure 10. DDX-23 and DDX-17 are required for biogenesis of several heterochronic

miRNAs...123

Figure 11. Reduction of DDX-23 or DDX-17 does not affect the expression of

machineries for miRNA biogenesis and function...124

Figure 12. DDX-23 and DDX-17 are required for efficient regulation of cog-1::gfp

expression by ectopic lsy-6 miRNA in the uterus...125

(16)

Figure 13. The spatial expression pattern of DDX-23...126

Figure 14. The model for DDX-23 and DDX-17 in miRNA biogenesis………...127

Figure 15. Depletion of HRP-2 relieved let-7(n2853) retarded seam cell development...128

Figure 16. HRP-2 genetically acts upstream of LIN-29...130

Figure 17. RNAi knockdown of HRP-2 promotes precocious LIN-29 expression at early stage...131

Figure 18. Reduction of HRP-2 enhances let-7-mediated repression of lin-41...133

Figure 19. hrp-2(RNAi) does not alter let-7 and miRISC levels...135

Figure 20. HRP-2 interacts with miRISC in an RNA-dependent manner...136

Figure 21. The let-7 binding site is not required for HRP-2 to interact with lin-41 mRNA 3’UTR...137

Figure 22. HRP-2 is associated with a 14-nt U-rich motif in lin-41 3’UTR...138

Figure 23. Deletion of HRP-2 response element (HRE) enhances let-7-mediated lin-41 repression...140

Figure 24. HRP-2 distributes either in nucleus and cytoplasm in C. elegans...142

(17)

lin-41/TRIM71 repression...144

Figure 26. hnRNP Q impedes let-7-mediated repression of TRIM71...146

Figure 27. hnRNP Q is associated and co-localized with miRISC in P-bodies...148

Figure 28. hnRNP Q binds to an element in TRIM71 3’UTR...150

Figure 29. The hnRNP Q response element (QRE) is required for hnRNP Q binding...151

Figure 30. Deletion of hnRNP Q response element increases repression of TRIM71 by let-7...153

Chapter 7 References...154

Appendix 1...170

Appendix 2...172

Appendix 3. Brief summary of the previous ‘RACK-1’ project...173

Appendix 4. The published article for the ‘RACK-1’ project...175

Appendix 5. The published article for the ‘DDX23’ part in this thesis...191

(18)

Chapter 1 Introduction

Chapter 1.1 miRNAs

1.1.1 Discovery of miRNAs

MiRNAs are around 22 nucleotides in length, small non-coding RNAs.

Initially, the first miRNA—lin-4 was discovered by genetically phenotypic analysis and

identified in C. elegans as a heterochronic gene, with fluctuating expression pattern 1.

Later, Lee et al. demonstrated that the lin-4 gene locus encodes a small non-translated

RNA fragment, which can partially complement to lin-14 mRNA 3’UTR 2. In the same

year, Wightman et al., also proposed that lin-4 post-transcriptionally down-regulates

LIN-14 expression by targeting these sites. Such a lin-4-mediated repression of lin-14

was therefore believed to play an important role in controlling developmental timing of

C. elegans 3. It was initially considered as a specific event in the nematodes until 2000

when the second small RNA, let-7, was characterized. At that time, let-7 was emerging

as a new member in heterochronic gene pathway. In addition, repression of its target

lin-41 by targeting the lin-41 3’UTR promotes the downstream adult stage-specific

transcription factor—LIN-29, which is important for determination of developmental

(19)

progresses 4,5. let-7 was also identified in other species, including Drosophila, Zebrafish,

mouse and human 6,7. So far, a growing body of miRNAs have been identified and their

expression are frequently correlated with diseases, development, and tumorigenesis 6,8,

leading to the interest of investigating functions and mechanisms of miRNAs involving

in various biological progresses.

1.1.2 miRNA family

Following identification of miRNAs in different species, the researchers

extracted some rules for the complementarity between miRNAs and their targets.

According to the computational method and experimental validation, they found that the

2-7 nucleotides of miRNAs are often completely complementary to the targets 9.

Afterward, these few nucleotides were defined as an critical motif for target recognition

and named as the ‘seed region’. Furthermore, they also demonstrated that a single target

could be regulated by the miRNAs sharing same sequences in the seed region. Based on

this property, these miRNAs therefore were classified into the same miRNA family, in

which they potentially serve as a modulator to control the same genes expression, such

as the let-7 family, lin-4/miR125 family and so on.

(20)

1.1.3 Functions of miRNA

Currently, over 70% of human protein-coding genes are predicted to be

regulated by miRNAs. Dysfunction or misregulation of miRNAs lead to severe

developmental defects, diseases or carcinogenesis. How do miRNAs perform their

functions? Post-transcriptionally targeting of cognate mRNAs by miRNAs restrains

their translation or promotes mRNAs degradation 10. Following the recognition and

targeting of the mRNAs in the cytoplasm, they will aggregate at a foci called the

Processing-body (P-body) for efficiently performing their functions 11. The miRNAs are

not working alone, they are associated with several components, including the core

protein Argonaut, GW182 and other partner proteins to form the microRNA-induced

silence complex (miRISC). Previous studies have demonstrated that the PABP (poly

adenine binding protein) has the ability to recruit miRISCs to the target mRNAs and

then facilitate their function 12. When miRISCs are brought close to mRNAs, the

GW182 protein facilitates the dissociation of PABP from the poly-A tail and also

recruits the CCR4-NOT1 deadenylase complex 13-15. Not only GW182, but also a

DEAD-box RNA helicase DDX6 directly interacts with deadenylase and modulates

16-18

(21)

complex to promote mRNA degradation19. Overall, the functions of miRNAs are

primarily to repress cognate mRNAs translation and subsequently promote turnover.

1.1.4 Biogenesis of miRNAs

A majority of miRNA biosynthesis starts with transcription of

primary-miRNAs (pri-miRNA) by RNA polymerase II or III. The products are

equipped with m7G cap and polyadenylated tail and featured with stem-loop secondary

structure 20-22. Recognition and digestion of it by a complex, composed of Drosha and

DGCR8, called “Microprocessor”, leads to generation of precursor-miRNAs, which

generally contains 60-80 nt and still retains the stem-loop secondary structure 23-27.

Subsequently, exportation of the pre-miRNAs into cytoplasm is done by the XPO5, an

exportin associated on the nucleus membrane. Then, the stem-loop structure can be

detected and processed by the Dicer complex to produce an approximately 22-nt long

miRNA duplex 28-31. One strand of the double stranded miRNA will be degraded and

the other one will be incorporated into functional miRISCs 32.

1.2 The let-7 miRNA

1.2.1 Regulation of let-7 biosynthesis

(22)

The biosynthesis of some miRNAs is more complicated and stringently

regulated, such as let-7. The phylogenetic conserved miRNA—let-7 had been identified

in a number of species with a high similarity in sequence 6. As other miRNAs, the

pri-let-7 is transcribed by RNA polymerase II and equipped with the cap and poly-A tail

structure both in mammals and nematode 33. Different to most other miRNAs, the

stem-cell specific regulator LIN28, an RNA-binding protein, recognizes pri-let-7 and

pre-let-7 intermediates and promotes degradation. Two LIN28 isoforms, A and B,

inhibit let-7 maturation in different cellular compartments via distinct mechanisms. In

the nucleus, LIN28A reduces the activity of Drosha/DGCR8 complex and thus blocks

the intermediate processing by targeting the terminal loop of pri-let-7 34-36. In the

cytoplasm, as a result of the association between LIN28B and pre-let-7, the terminal

uridyl transferase (TUTase) is recruited to the LIN-28-pre-let-7 complex to uridylate the

3’ of pre-let-7 37,38. Later, the uridylated intermediate will be degraded by a 3’-5’

exonuclease, DIS3L2 39. The way to regulate let-7 biosynthesis by LIN28 is highly

conserved among species, indicating the significance of regulating let-7 biogenesis

during evolution 38,40,41. In addition, the hnRNP A1 and KSRP also reported as

(23)

pre-let-7 42. Taken together, these evidences suggest that let-7 biogenesis requires

stringently regulated and the detail mechanism is worth to further investigate.

1.2.2 The role of let-7 in maintaining stem cell stemness

Determination of stem cell differentiates or divides has long been a big

question for scientists. Well-controlled proliferation by the cell cycle is associated with

proper development, organogenesis and numerous aspects of biological progresses 43.

Mis-regulation of cell growth leads to diseases and carcinogenesis 44. The tumor

suppressor let-7 miRNA modulates expression of a bundle of proteins—most

of them are important for cell cycle progression 45,46. For example, let-7 regulates the

MYC transcription factor for several cell cycle genes 46, and LIN28, which both are

required for the induced pluripotent stem cell (iPSCs) transformation 33,47. As

mentioned above, LIN-28 negatively controls let-7 miRNA biogenesis. Therefore, let-7

and LIN-28 form a negative feedback regulation loop to modulate the cell cycle. In

addition, the high mobility group AT-hook 2 (HMGA2), a transcriptional positive

regulator to promote cell cycle, commonly associated with tumorigenesis 48, is also a

let-7 target. Interestingly, the HMGA2 3’UTR contains eight let-7-complementary sites

(LCS), implying the potential for being a competing endogenous RNA (ceRNA) to

(24)

reduce the impact of let-7-mediated repression to other targets 49. RAS, another let-7

target, functions as a binary molecular switch that controls intracellular signaling

networks. RAS activates several pathways, of which the mitogen-activated protein

(MAP) kinase cascade has been well-studied. This cascade transmits signals

downstream and results in the transcription of genes involved in cell growth and division 50. Beside to other let-7 targets, the potential E3 ubiquitin ligase

LIN-41/TRIM71 controls the degradation of Argonaut protein, the core enzyme in

miRISC 51. Expression of LIN-41/TRIM71 is required for appropriate development in

animals. However, overexpression of LIN-41/TRIM71 in adults leads to carcinogenesis

52,53. Recently, the let-7/LIN-41 pathway had been reported as an important factor for

the fates decision of stem cells 54. Taken together, these targets of let-7 serve as

important roles in modulating cell cycle progression, reflecting the significant role for

let-7 in regulating stemness maintenance.

1.2.3 The evolutionary conserved let-7/lin-41 regulatory pathway

LIN-41 was first identified in C. elegans as a phenotype suppressor of

let-7(n2853) and thus classified as a member in the heterochronic gene pathway, in

(25)

Subsequently, the LIN-41 homologs, called TRIM71 in mammals, were found

evolutionarily conserved in diverse species, such as in D. melanosgater, C. elegans,

Zebrafish, mouse and human 55. Over the past decades, the investigation in controlling

LIN-41/TRIM71 expression shows that let-7-mediated regulation seems to be the major

way to modulate its levels in numerous species 4-6,52. Developmental defects were

observed in animals without proper tuning of the let-7/lin-41 pathway, indicating the

importance of this pathway in development for these species and showing that the detail

mechanism in let-7/lin-41 pathway can be studied by using a simple model organisms,

such as C. elegans.

1.3 The DExD/H-box RNA helicases

1.3.1 Functions of DExD/H-box RNA helicases

The DExD/H-box RNA helicases family, including the DEAH, DExH, DExD

subfamilies, was highly conserved among species from bacteria to humans. According

to the current knowledge, they are involved in nearly all processes of RNA metabolism

steps such as transcription, mRNA splicing, ribosomal biogenesis, mRNA export,

translation, and RNA turnover 56. Initially, they were named based on the amino acid

sequence D-E-A-D (Asp-Glu-Ala-Asp) or D-E-A-H (Asp-Glu-Ala-His) in their

(26)

conserved motif II. With extensive homology, there are eight conserved motifs that

form the helicase core within the ATPase and helicase activities. Depending on the

auxiliary domains, which are often located in the amino-terminus and carboxyl-terminus

ends, and bound cofactors, the helicase core of the DExD/H-box proteins can catalyze

different types of conformational changes and nucleic acid rearrangements, such as

single strand translocation, duplex annealing or displacement. Many DExD/H-box

proteins also displace RNA-protein interaction and facilitate the remodeling of large

ribonucleoprotein (RNP) complexes 57,58.

1.3.2 The implication of DExD/H-box RNA helicases in the miRNA pathway

During the past decade scientists have attempted to understand the molecular

mechanisms of miRNA biogenesis and function. It is reasonable to expect great

DExD/H-box RNA helicase activities associated with miRNA since there are numerous

conformational changes in multiple-step miRNA processes. However, it seems that only

few helicases have been implicated for their roles in the miRNA pathway so far.

p68/p72 and DDX1 are components of the larger Microprocessor complex and are

required for processing of a subset of miRNAs 23,59,60. RCK/p54/CGH-1 interacts with

(27)

target repression 18. Recently, C. elegans CGH-1 has been shown in association with a

TRIM-NHL protein, NHL-2, and this complex interacts with miRISC components and

modulates miRNA function 61. Overall, these evidences suggest the critical role for

DExD/H-box RNA helicases in miRNA biogenesis or function and raise the possibility

that maybe there are novel helicases in the pathway.

1.4 The heterogeneous nuclear proteins (hnRNPs)

1.4.1 Functions of hnRNPs

The heterogeneous nuclear ribonucleoproteins (hnRNPs) are RNA-binding

proteins with critical roles in almost all aspects of nucleic acid metabolism, including

transcription, protecting of nascent RNAs, mRNA splicing, translational control and so

on. Despite they share some general characteristics, the variations of the domain

composition and the functions of hnRNPs are large between each others. There are ~20

proteins (named hnRNP A-U) consisting of multiple RNA-binding domains, including

RRM (RNA recognition motif), KH (K homology), atypical RRM and glycine-rich

domains (for a review see ref. 62). During the past decades, hnRNPs gain-of-function or

loss-of-function have been shown to be associated with carcinogenesis 63. For example,

several hnRNPs are required for the length maintenance of telomere. Shortening of the

(28)

telomere results in tumorigenesis and cancer progression 64. Defects in mRNA splicing

and alternative splicing are common events in cancer development, such as that

mis-splicing of the cell proliferation regulator c-Src by hnRNP A1 and H leads to

carcinogenesis 65-67. These evidences indicate the important roles for hnRNPs in tumor

progression, however, little is known about the involvement of hnRNPs in miRNA

pathway and miRNA-related tumorigenicity.

1.4.2 The potential role of hnRNPs in the miRNA pathway

To date, a few hnRNPs had been implicated in miRNA biogenesis and

function. For example, the nuclear hnRNP A1 stabilizes pri-miR-18a stem-loop

structure to promote Drosha-mediated processing 68. By contrast, the binding of hnRNP

A1 to the terminal loop of pri-let-7a-1 inhibits the Drosha-mediated processing by

directly competing with an RNA-binding protein KSRP that facilitates the processing 69.

In addition, a recent study showed that hnRNP E1 binds to several evolutionarily

conserved CU-rich elements of human endothelial nitric oxide synthase (eNOS) mRNA

to prevent miR-765-mediated repression 70. Moreover, hnRNP Q has been shown to

compete with the poly(A) binding protein (PABP) for binding to the poly(A) tail in

(29)

with GW182, a core component of miRISC 72,73, hnRNP Q has been proposed to play a

negative role in miRNA-mediated repression of poly(A)+ mRNAs 74. However, whether

any else hnRNPs are required for miRNA biogenesis and/or function remain elusive.

1.5 The animal model—Caenorhabditis elegans

1.5.1 The advantages of using C. elegnas as an animal model

As an excellent animal model, Caenorhabditis elegans is used to study in a

variety of biological processing, including apoptosis, signaling pathway, cell cycle, cell

polarity, gene regulation, metabolism, ageing, sex determination and miRNA regulation.

With several characteristics, such as the completely sequenced genome composition, the

light-transmittable body for easy observation and the short life cycle, the C. elegans has

become a useful tool for investigators 75. Furthermore, during the process of

development, the heterochronic gene pathway is essential for proper determination of

developmental timing 1. Involvement of miRNAs in this pathway helps scientists, who

are interesting in investigation of miRNA biogenesis and functions, to get an easier way

to reach their goals.

1.5.2 The heterochronic gene pathway and let-7 miRNA in C. elegans

(30)

In C. elegans, the heterochronic gene pathway is an excellent model for

studying miRNAs because it acts as binary switches to control temporal development,

which can be easily monitored. In the early larval development, the lin-4 miRNA

represses its target lin-14 and mediates the L1-to-L2 switch. The L2-to-L3 switch is

mediated by lin-4 and the let-7 family (mir-48, -84, and -241) repressing lin-28 and

hbl-1. Finally, let-7 repression of lin-41 and hbl-1 mediates the L4-to-adult switch and

controls terminal differentiation. Since the let-7 mutants cause traceable phenotypes,

they have been used in genetic analysis to determine the interaction with other genes in

the miRNA pathway, including functional partners or downstream targets 76-78. The

temperature-sensitive mutant allele let-7(n2853) carries a G-to-A substitution in the

seed region of the mature let-7 miRNA that reduces target silencing and also the level of

let-7 miRNA 79. let-7 loss-of-function results in heterochronic phenotypes such as

retarded hypodermal cell differentiation and vulval abnormalities. The mutant animals

die by bursting through the vulva at the L/A switch 4,80. Knocking down of let-7

downstream targets usually suppresses the phenotypes 76. Knocking down negative

functional partners of let-7 has also been shown to suppress the lethality of the

(31)

modulating target silencing 81,82. On the other hand, a weak allele of let-7, let-7(mg279),

slight reducing the level of mature let-7 due to processing defects, not severe enough to

cause the vulval bursting phenotype, could be a sensitized background in which to

detect other defects in the miRNA pathway 20,83 . Indeed, the let-7(mg279) has been

utilized in synthetic-lethal screens by which several functional factors in the miRNA

pathway have been identified 78.

1.5.3 Controlling of vulval development by miR-84-mediated repression of

let-60/RAS

The oncogenic protein RAS activates proteins necessary for the propagation

of growth factor and other receptors signal such as c-Raf and PI 3-kinase and therefore

promote tumorigenesis (for a review see reference 84) . LET-60 is the homolog of RAS

in C. elegans. Initially, scientists found that the let-60 gain-of-function animals

exhibited extra-vulva or also called multi-vulva phenotype 85,86. Following that, they

found it is a target of miR-84, one of the members in let-7 family. The relieved

protrusion number of vulva by overexpressing miR-84 also supported this idea 87,88.

Finally they found that, during the process of vulva development, only the P6.p cell, one

of the vulva precursor cell, continuously expresses LET-60 and finally it will develop

(32)

into the vulva structure. Expression of miR-84 in other precursor cells down-regulates

LET-60 level to ensure only one precursor cell turn into vulva tissue 87. The multi-vulva

phenotype caused by let-60 gain-of-function is easy traceable and observable, making it

a useful tool to monitor the miR-84 activity in C. elegans 61,87,88.

1.5.4 The lsy-6 miRNA-mediated repression of cog-1

The lsy-6 miRNA is one of the most famous miRNAs in C. elegans and not

included in the heterochronic pathway. It functions as a determinant to control the

specification and differential gene expression of two morphologically similar and

bilaterally symmetric neurons, ASEL and ASER. The expression of lsy-6 miRNA is the

ASEL-specific and promotes down-regulation of a key lsy-6 target, the transcription

factor COG-1. In animals without lsy-6 expression, the ASEL neurons employ the

ASER fate due to derepression of COG-1 89. In addition to ASEL/R, the expression of

COG-1 also observed in tissues that do not normally express lsy-6 miRNA, including

the vulva and uterus 90. Utilization of ectopic expressed lsy-6 by the cog-1 promoter can

down-regulate COG-1, for example, in vulval and uterine tissues 89. Therefore, it could

serve as a useful tool to examine the impact of interested genes RNAi on lsy-6-mediated

(33)

1.6 Project aims

Since miRNAs regulate more than 60% of human protein-encoding genes and

mis-function of miRNAs directly associates with various types of cancers, to better

understand the mechanisms of miRNA action is certainly important. In the thesis, I use

genetic analysis of the alleles let-7(2853) or let-7(mg279) to discover novel factors,

including DExD/H-box RNA helicases and hnRNPs, which potentially function in the

miRNA pathway.

(34)

Chapter 2. Materials and methods

2.1 Caenorhabditis elegans

2.1.1 Strains

The C. elegans strains used in this thesis are listed below:

Strain name Genotype Source

Bristol N2 Wild type Dr. Wu, Y.-C., Taiwan

SPN004 eri-1(mg366) IV; let-7(mg279) X Dr. Ruvkun, G., USA SPN007 eri-1(mg366) IV; wIs51[SCM::gfp,

unc-119(+)] V; let-7(mg279) X Homemade SPN008 wIs51[SCM::gfp, unc-119(+)] V;

let-7(mg279) X Homemade

FT250 xnIs96[pJN455(hmr-1p::hmr-1::GFP::u

nc-54 3'UTR) + unc-119(+)] CGC, USA

maIs105[col-19::gfp] Dr. Grosshans, H., Switzerland

MT2124 let-60(n1046gf) CGC, USA

GR1689 let-60 (n1046gf); mir-84(tm1304) Dr. Ruvkun, G., USA GR1690 mgIs45[mir-84++]; let-60(n1046gf) Dr. Ruvkun, G., USA PS3662 syIs63[cog-1::GFP + unc-119(+)] CGC, USA

OH7310

syIs63[cog-1::GFP + unc-119(+)];

otIs193 [cog-1p::lsy-6hp + rol-6(su1006)]

CGC, USA

SPN133 ddx-23::GFP::3xFLAG Homemade

MT7626 let-7(n2853) X Dr. Slack, F. J., USA

SPN016 wIs51[SCM::gfp, unc-119(+)] V;

let-7(n2853) X Homemade

(35)

2.1.2 Culture

Except the worms carrying the let-7(n2853) mutant allele were cultured at its

permissive temperature 15°C, the others were maintained under standard condition at 20

°C as previously described 91. In brief, the animals were placed onto the nematode

growth media plate (NGM plate: 17 g bacto-agar, 2.5 g tryptone and 3 g NaCl for 1 L)

with sufficient E. coli OP50 on the surface of agar.

lin-29(n333) II; wIs51[SCM::gfp,

unc-119(+)] V Homemade

lin-29(n333) II; maIs105[col-19::gfp] Homemade MT19756 nIs408 [lin-29p::lin-29::mCherry +

ttx-3p::GFP] CGC, USA

HW769 pwrt-2::gfp::lin-41 3′ UTR Dr. Grosshans,

H., Switzerland

HW783 pwrt::gfp::lin-41 3′ UTR∆LCS Dr. Grosshans,

H., Switzerland

HW786 pwrt-2::gfp::unc-54 3′ UTR Dr. Grosshans,

H., Switzerland EG3366 ttTi5605 II; unc-119(ed3) III; oxEx1578

[eft-3p::GFP + Cbr-unc-119] CGC, USA SPN062 pwrt-2::gfp::lin-41 3′ UTR Homemade SPN063 pwrt::gfp::lin-41 3′ UTR∆HRE Homemade SPN064 pwrt::gfp::lin-41 3′ UTR∆LCS Homemade SPN065 pwrt::gfp::lin-41 3′ UTR∆LCS∆HRE Homemade

Phrp-2::gfp::hrp-2 Homemade

(36)

2.1.3 RNA-interference (RNAi)

All the RNAi experiments for C. elegans used in this thesis were feeding

RNAi. The E. coli strain HT115 carrying IPTG inducible expression vectors, in which

the dsRNA can be expressed to against specific genes by driving the two T7 promoter

located at each side of interested gene fragments. In order to get the same growth rate of

worms, we harvested the embryo from gravid adults as mentioned in previous study 92.

In summary, animals were collected and precipitated by gravity in M9 buffer.

Discarding the supernatant and supplementing 0.75 mL 5N NaOH and 1.5 mL bleach to

the final volume is 7.5 mL in the 15 mL centrifuge tube. It was immediately undergone

the vigorously votex for around 3-5 minutes to dissolve worm bodies and release

embryos. Following 3000 rpm centrifugation for 1 minute, the supernatant was removed

and supplemented with M9 buffer to wash the embryo pellet. After three times repeat of

centrifugation and washing pellet, the embryos were soaked in a few volume (usually

3-5 mL) of M9 buffer and left in 20 °C with constantly rotating overnight. The next day,

synchronized L1 animals were then subjected into plates that were seeded with bacteria

carrying control or RNAi clone against genes of interest two days before. Following 30

(37)

subsequent assays.

2.2 Construction of plasmids

2.2.1 C. elegans RNAi clones

The pL4440 vector was digested with restriction enzyme EcoRV to produce a

blunt-end cutting site. Following the alkaline phosphatase (CIP) (NEB, #M0290)

treatment, the linearized vector was incubated with the PCR-amplified interested gene

fragment, which had been blunted by the kit from NEB (#E1201) according to the

manufacture’s instructions, and then ligated by T4 DNA ligase at 16°C overnight. The

detail information of RNAi clones and the primer sets used for newly generated RNAi

clones in this thesis are listed in Appendix 1 and 2.

2.2.2 C. elegans expressing plasmids

The Multisite Gateway system (Invitrogen) was used to generate genomic

DNA fragment-based expression vector for C. elegans and the procedure was according

to the instruction mentioned previously 93. Briefly, as a promoter region, the ~3000 bp

upstream of the start codon (ATG) was PCR-amplified and carrying attB4 and attB1r

site for BP clonase (Invitrogen) recognition. Following the BP reaction, recombining of

(38)

the promoter region into pDONRP4P1r vector leads to generation of the 5’ entry clone.

The universal tag, such as HA and GFP, with start codon was amplified and inserted

into the pDONR221 middle entry clone. The fragment for 3’ entry clone was amplified

by the primers start from the coding region without start codon and stop with the end of

3’UTR, which was according to the sequence published in NCBI database. After

insertion of this fragment into pDONRP2rP3 vector, the 3’ entry clone was ready for

subsequent steps. For BP reactions, 150 ng of vector and 10-150 ng of insert were mix

and supplemented with sterile water to the final volume is 8 µL. For each reaction, 2 µL

BP clonase (Invitrogen, #11789020) is sufficient. Following overnight incubation at

room temperature, the reaction was transformed into E. coli DH-5α strain by heat shock.

After sequence validation of these three entry clones, the 5’, middle and 3’, they were

used as the materials for LR reaction. 150 ng of each entry clone were mixed in a

microcentrifuge tube and plus 50 ng of the destiny vector, pCFJ150 for MosSCI and

pGC188 for conventional injection method in this thesis, to the final volume is 8 µL.

Following incubation at room temperature overnight after supplemented 2 µL LR

clonase (Invitrogen, #11791100), the reaction was transformed into E. coli DH-5α strain

(39)

ready for subsequent use to inject into worms to express the gene of interest.

2.2.3 TRIM71 3’UTR fused luciferase plasmids

The TRIM71 3’UTR and an LCS-deleted version were artificially synthesized

and inserted into a vector (IDT custom gene synthesis). Following digested with NotI

and XhoI, the purified TRIM71 3’UTR fragments were subjected into the ligation

reaction with the linearized psicheck2 luciferase vector at 16 °C overnight in water bath.

To delete the hnRNP Q response element, we designed a primer pair contains the

restriction enzyme site for XhoI in forward primer:

ATCGCTCGAGTTGCATTTCCTAGGTTTCTGTGT and NotI in reverse primer:

GCCAGCGGCCGCAGTAGTTTTTTTTTGTGTTTCCT to generate the fragment

without this element (24 bp deletion). After amplified and digested the PCR fragments,

the ligation reactions were performed as the same condition as the full-length TRIM71

3’UTR.

2.2.4 hnRNP Q1 plasmids

For constructing HA-hnRNP Q1, the primer set complement to hnRNP Q1

coding region was used for PCR amplification. The DNA oligo sequence for the

(40)

forward primer is TTCAATCGATGGGCTACAGAACATGTTAAT and reverse primer

is TCCCGATCGATTCATTGTAACAGGTCAGGA. The ClaI recognition sites (the

sequence underlined) were artificially introduced to each end of primers. Following

amplified the coding region and digested by ClaI, the fragment was placed into the

ligation reaction with linearized pKH3 vector at 16 °C overnight in water bath. For

constructing hnRNP Q1-mCherry, the primer pair, forward:

ATCCGCTAGCATGGCTACAGAACATGTTAA and reverse:

ATGCAGATCTTTGTAACAGGTCAGGACCGG, were designed and used to amplify

the hnRNP Q1 cDNA with the recognition sites for NheI at 5’ and BglII at 3’ end,

respectively. Following the digestion reaction by these restriction enzymes, the PCR

amplified fragment was subjected into ligation reaction with the linearized

pDEST-mCherry-N1 vector, digested by NheI and BamHI, at 16 °C overnight in water

bath. Single colonies of these constructs after E. coli transformation were selected

following sequenced.

2.2.5 GFP-Ago2 plasmid

The pEYFP-C1-Ago2 was a kind gift from Dr. Chia-Ying Chu (National

(41)

restriction enzymes, we subjected the purified Ago2 fragment into the ligation reaction

with the digested pEGFP-C1 vector at 16 °C overnight in water bath. The single

colonies were selected and sequenced to get the pEGFP-C1-Ago2 construct.

2.3 Microscopy analysis

For numbering the worms burst from vulva, we directly counted the animals

on plates by using a dissecting microscopy. For imaging, animals were collected and

mounted on the agar pad contains 2% Agarose I (amresco, #9012-36-6). Prior to cover

the coverslips, the worms were soaked in 20 µL 1 mM Tetramisole Hydrochloride

(Sigma, #L9756) for anesthesia. The image were obtained and analyzed by the Zeiss

Axiovision system.

2.4 RNA isolation

2.4.1 From C. elegans

The animals for total RNA purification were collected and washed

sufficiently by M9 buffer. The worm pellet was resuspended by 1 mL of Genezol

(Geneaid, #GZR100) and put into a 2-mL screw cap tube contains 0.5 mL sterile

Zirconia beads. Following the homogenization of the mixture by the homogenizer (M.P.

(42)

Biomedicine, FastPrep 24), 200 mL chloroform was added into each tube. Subsequently,

the centrifugation was performed at 12000 g for 15 minutes at 4 °C to separate the water

phase and oil phase. The water phase was then moved to a new 1.5 mL microcentrifuge

tube. Following 10 minutes incubation of the equal amount isopropanol, the

centrifugation was performed at 12000 g for 20 minutes at 4 °C. After removing the

supernatant and washing the pellet by 70% ethanol at 12000 g for 5 minutes at 4 °C, the

RNA was dissolved by proper amount of DEPC treated water.

2.4.2 From human cell cultures

The pelleted cells or cell lysates were used to isolate total RNA by

introducing 1 mL Genezol (Geneaid, #GZR100). After incubation at room temperature

for 10 minutes, each tube was added 200 mL chloroform and mixed thoroughly. The

supernatant was moved into a new tube following the 15 minutes centrifugation at

12000 g at 4 °C. After 10 minutes incubation of the equal amount isopropanol, the

centrifugation was performed at 12000 g for 20 minutes at 4 °C. After removing the

supernatant and washing the pellet by 70% ethanol, the RNA was dissolved by proper

amount of DEPC treated water.

(43)

2.5 Northern blot analysis for small RNAs

For detection of miRNAs, 10 µg of total RNA samples, per lane, were

separated by 12% polyacrylamide gels (8 M urea, Acrylamide/Bis 19:1) and transferred

onto Hybond-N+ membranes (GE Healthcare, #RPN119B). RNA was cross-linked to

the membrane by 254 nm UV light irradiation (120000 microjoules/cm2) for each side

of the membrane and then baking at 80 °C for 1 hour. Short RNA probes

complementary to miRNAs or U6 snRNA were prepared by in vitro transcription using

T7 RNA polymerase as previously described 94. Generally, the reaction was mix up with

3 µL master mix, contains 6.67 µM ATP, UTP, GTP and 1X T7 RNA polymerase

buffer, 10.5 µL 5 µM DNA template, 1 µL Superas-In (Ambion, #AM2694), 4 µL

32P-alpha-CTP (3000 uCi/mole) and 1.5 µL T7 RNA polymerase (NEB, #M051) to the

final volume is 20 µL. To generate the DNA templates for in vitro transcription, the

independent DNA oligos were synthesized and heat annealed. For annealing of two

independent but complement oligos, the mixture contains 5 µM of each DNA oligos

was heated at 95 °C for 5 minutes and then put at room temperature to allow the oligos

anneal together. The sequence of DNA oligos used in this thesis were summarized and

listed below.

(44)

T7Top

GAA ATT AAT ACG ACT CAC TAT AGG

T7let-7 btm

TGA GGT AGT AGG TTG TAT AGT TCC TAT AGT GAG TCG TAT TAA TTT C

T7lin-4 btm

TCC CTG AGA CCT CAA GTG TGA CCT ATA GTG AGT CGT ATT AAT TTC

T7miR-48 btm

TGA GGT AGG CTC AGT AGA TGC GAC CTA TAG TGA GTC GTA TTA ATT TC

T7miR-241 btm

TGA GGT AGG TGC GAG AAA TGA CCT ATA GTG AGT CGT ATT AAT TTC

T7miR-84 btm

TGA GGT AGT ATG TAA TAT TGT AGA CCT ATA GTG AGT CGT ATT AAT TTC

T7U6 btm

GGA TGA CAC GCA AAT TCG TGC CTA TAG TGA GTC GTA TTA ATT TC

*Note: The sequence underlined is the site for T7 RNA polymerase recognition.

Hybridization was performed at 55 °C in 0.36 M Na2HPO4, 0.14 M NaH2PO4,

1 mM EDTA, 10% SDS, 25% Formamide and 0.1 mg/ml salmon sperm DNA. Washes

were done at 55 °C twice in the low stringency buffer (4× SSPE and 4% SDS) and

twice in the high stringency buffer (0.1× SSC and 0.1% SDS). Radioactive signals were

detected by a storage phosphor image plate and the Typhoon Trio Variable Mode

Imager (GE Healthcare) or exposed onto the radioisotope-sensitive films (Kodak,

#Z363073).

(45)

2.6 RT-PCR and RT-qPCR

2.6.1 Poly-A tail-based reverse transcription and qPCR

For detecting the total pri-let-7 (the sum of pri-let-7A, pri-let-7B and

SL1-pri-let-7) by qPCR, up to 1 µg of total RNA was used and subjected into poly-A

tail-based reverse transcription. Briefly, the sample was mixed with reagents listed as

follows and heat at 65 °C then cool-down to 4 °C to anneal the universal RT-primer

containing a VN anchor, oligo(dT) and the universal reverse PCR primer sequence,

called URT primer, as previously described approach 95.

Annealing of poly-A tail-based URT primer

RNA sample (up to 1 µg) 10 µL

50 µM URT primer 1 µL

10 mM dNTP mix 1 µL

Nuclease free water 1 µL

Subsequently, following waiting at least 1 minute for incubation of the

reaction at 4 °C, reagents listed below were added into the tube and then the reaction

was subjected into reverse transcription.

Reagents for poly-A tail-based reverse transcription

Primer annealed RNA sample 13 µL

(46)

5X First-strand buffer 4 µL

0.1 M DTT 1 µL

Superase-In (Ambion, #AM2694) 0.5 µL

Superscript III (Invitrogen, #18080044) 0.5 µL

Nuclease free water 1 µL

Final volume 20 µL

The program for reverse transcription was initiated from activating the

enzyme by keeping the temperature at 25 °C for 5 minutes. Next, for best activity of

RTase, the temperature was set at 55 °C for one hour. Finally, to stop the reaction, heat

inactivation was performed by setting the temperature at 70 °C for 15 minutes. The

RNA templates were eliminated by adding 1 µL RNase mixture, which contains 2.5 unit

RNase H (NEB, #M0297) and 5 µg RNase A (QIAGEN, #19101), and incubating at 37

°C for 20 minutes.

To perform the quantitative-PCR, the KAPA SYBR FAST qPCR kit was used

according to the manufacture’s instructions. The reagents used in qPCR were listed in

the table below.

Reagents for poly-A tail-based quantitative-PCR

50X diluted cDNA 5 µL

(47)

Forward primer (10 µM) 0.4 µL

Reverse primer (10 µM) 0.4 µL

Nuclease free water 4.2 µL

Final volume 20 µL

For detecting the signals, the ABI Prism 7000 system was used and the

program was set as follows.

Program used for detecting poly-A tail based quantitative-PCR

Step 1 95 °C 3 minutes Activate enzyme

Step 2.1 95 °C 30 seconds Denaturing DNA

Step 2.2 60 °C 30 seconds DNA synthesis

Detect the signals at the end of this step at each cycle and repeat step 2 for 40 cycles

Step 3 60-95 °C Dissociation

The sequences of oligonucleotides used in this assay are listed in the table below.

URT primer

5’-AAC GAG ACG ACG ACA GAC TTT TTT TTT TTT TTT VN-3’

Total pri-let-7 forward (L1)

5’-GCA TCT ACC TCG ATT GGA CCT A-3’

eft-2 forward

5’-GTG CTA ATC CAC CTC TGG AA-3’

Universal reverse primer (R1)

(48)

5’-AAC GAG ACG ACG ACA GAC TTT-3’

2.6.2 Random priming-based reverse transcription and qPCR

This assay was used to examine the presence or abundance of mRNAs or

primary miRNAs. 10 µg of total RNA was treated with DNase I (Ambion, #AM1907),

in the final volume is 20 µL for at least 30 minutes at 37 °C. The DNase was inactivated

by adding 4 µL of inactivation reagent with constantly tapping of the tubes for 5

minutes at room temperature. Following brief centrifugation for a few seconds, 10 µL of

the supernatant was used for subsequent steps. The cDNA was synthesized by

SuperScript III reverse transcriptase (Invitrogen, #18080044) using random hexamers.

The detail information of reagents used in cDNA synthesis is listed in the table below.

Annealing of random priming-based primers

DNase treated RNA sample (around 5 µg) 10 µL

100 ng/µL Random hexamers 1 µL

10 mM dNTP mix 1 µL

Nuclease free water 1 µL

(49)

Following adding reagents, the tube was put into a PCR cycler and the

program was set as 65 °C for 5 minutes and cool-down to 4 °C at least 1 minutes to

allow the primers to properly attach the RNA molecules. Prior into the cDNA synthesis,

several reagents were added into the tube as listed below.

Reagents for random priming-based reverse transcription

Random hexamers annealed RNA sample 13 µL

5X First-strand buffer 4 µL

0.1 M DTT 1 µL

Superase-In (Ambion, #AM2694) 1 µL

Superscript III reverse transcriptase (Invitrogen, #18080044) 1 µL

The program for cDNA synthesis was initiated from 5 minutes at 25 °C to

activate RTase and then one hour at 50 °C for enzyme functioning and finally stopped

by inactivating the enzyme for 15 minutes at 70 °C. The RNA templates were

eliminated by adding 1 µL RNase mixture, which contains 2.5 unit RNase H (NEB,

#M0297) and 5 µg RNase A (QIAGEN, #19101), and following incubation at 37 °C for

20 minutes.

(50)

To perform the quantitative-PCR, the KAPA SYBR FAST qPCR kit was used

according to the manufacture’s instruction. The reagents used in qPCR were listed in

the table below.

Reagents for poly-A tail-based quantitative-PCR

10-50X diluted cDNA 5 µL

2X SYBR FAST master mix (KAPA, #KK4600) 10 µL

Forward primer (10 µM) 0.4 µL

Reverse primer (10 µM) 0.4 µL

Nuclease free water 4.2 µL

Final volume 20 µL

For detecting the signals, the ABI Prism 7000 system was used and the program was set

as follows.

Program used for detecting poly-A tail based quantitative-PCR

Step 1 95 °C 3 minutes Activate enzyme

Step 2.1 95 °C 30 seconds Denaturing DNA

Step 2.2 60 °C 30 seconds DNA synthesis

Detect the signals at the end of this step at each cycle and repeat step 2 for 40 cycles

Step 3 60-95 °C Dissociation

The sequences of oligonucleotides used in this assay are listed in the table below.

(51)

Primers used in random priming-based quantitative-PCR For C. elegans

SL1-pri-let-7_forward (L2) 5’-GGTTTAATTACCCAAGTTTGAGGC-3’

pri-let-7 and

SL1-pri-let-7_reverse (R2)

5’-CGCAGCTTCGAAGAGTTCTG-3’

pri-let-7_forward (L3) 5’-TCCTAGAACACATCTCCCTTTGA-3’

pri-miR-84_forward 5’-ATTTGGCGATGCGAGAAAGT-3’

pri-miR-84_reverse 5’-AGGCAGACGTATGATGAATA-3’

pri-lin-4_forward 5’-GACAATTTCTAGAGTTTTGGTTGG-3’

pri-lin-4_reverse 5’-CCTTTTCCCCGAATACCATT-3’

pri-miR-241_forward 5’-GTTCGGAATGGATTTTGGTTG-3’

pri-miR-241_reverse 5’-AGTGATGTTTCGATCTCCAC-3’

drsh-1_forward 5’-CGGACAAGACCGGAGAAGTA-3’

drsh-1_reverse 5’-CGTTTCCCAAACCTTTTTCA-3’

pash-1_forward 5’-GATTGCAGCGAATGATGAGA-3’

pash-1_reverse 5’-TCCTCAACCATTCCATCACA-3’

dcr-1_forward 5’-TGGTGGTGATGTCTCGAAAA-3’

dcr-1_reverse 5’-TCCCAACGTCAGCAAATGTA-3’

alg-1_forward 5’-TGCGCAGAAAGTATCGTGTC-3’

alg-1_reverse 5’-CTCTGGTGGCAGGTAGGTGT-3’

tbb-2_forward 5’-CAAATTCTGGGAGGTCATCTC-3’

tbb-2_reverse 5’-CATACTTTCCGTTGTTGGCT-3’

(52)

lin-42_forward 5’-TCTTGTTCACGTGCACCTTC-3’

lin-42_reverse 5’-GGCTCCGTCTGGCATAGTAA-3’

eft-2_forward 5’-TGTGTTTCCGGAGTGTGTGT-3’

eft-2_reverse 5’-CCATCGTCGTCTCCGTAAGT-3’

lin-41_forward 5’-GGATTGTTCGACACCAACG-3’

lin-41_reverse 5’-ACCATGATGTCAAACTGCTGTC-3’

gfp_forward 5’-ACCAGACAACCATTACCTGTCC-3’

gfp_reverse 5’-TCCCAGCAGCTGTTACAAACTC-3’

For mammalian cells

TRIM71_forward 5’-TGTGAGCTGCTGTGGAAGGT-3’

TRIM71_reverse 5’-GTCTTCAGCTCCTGCACCTG-3’

Renilla_forward 5’-GCCTAAGATGTTCATCGAGT-3’

Renilla_reverse 5’-TACTGCTCGTTCTTCAGCAC-3’

2.7 Lysate preparation

2.7.1 For C. elegans western blot analysis

The lysates were made according to previously described with little

modifications 96. Briefly, packed animals were collected and washed twice with 4-fold

volumes of wash buffer (50 mM Tris-HCl at pH 7.5 and 10 mM potassium acetate)

followed by centrifugation at 3000 rpm for 1 min. The animals were resuspended in

(53)

4-fold volume of homogenization buffer [50 mM Tris-HCl at pH 7.5, 10 mM potassium

acetate, 5 mM DTT, 10 U/ mL Superase-In (Ambion, #AM2694), and 1X Complete

protease inhibitor (Roche, #11697498001)] and incubated for 20 min on ice with

intermittent agitation. The animals were then rubbed by using a 1.5 Pellet Pestle and a

handy motor for 1 minute, with 10 seconds pulsing for each 10 seconds rubbing. The

homogenate was incubated for 20 min on ice after 2 mM magnesium acetate was added

and the concentration of potassium acetate was adjusted to 100 mM. Then centrifuged

at 13200 rpm for 10 minutes at 4 °C. The supernatant was used as cell extracts in

western blot analysis.

2.7.2 For C. elegans immunoprecipitation experiment

Worm lysates for immunoprecipitation (IP) were made according to

previously described with a few modifications 97. In brief, the pelleted worms were

homogenized in 5 volumes of IP buffer [10 mM Hepes-KOH, 250 mM NaCl, 0.5%

NP-40, 10% glycerol, 5 mM EDTA, 1 mM DTT, 1X Protease Inhibitors (Roche,

#11697498001)] for three times 30 seconds homogenous at 4 °C, with 5 minutes

interval for each action. The homogenate were then centrifuged at 10,000 rpm for 20

min at 4 °C. The supernatant was moved to a new microcentrifuge tube and used as cell

(54)

extracts for immunoprecipitations. The total protein concentration was determined using

the Bradford reagent (Amresco, #M172).

2.7.3 For mammalian cell lines western blot analysis

Lysis of cultured mammalian cells was performed as described in previous

study 98. In summary, the collected cells were washed twice by 1 mL cold PBS buffer

(137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, adjusted the final pH

value to 7.4). The packed cell pellet was lysed by adding appropriate volume of RIPA

lysis buffer (150 mM NaCl, 5 mM EDTA pH 8, 1M Tris pH 8, 1% NP-40, 0.5% sodium

deoxycholate and 0.1% SDS). Following incubation on ice for 30 minutes, the lysate

was centrifuged at 13200 rpm for 15 minutes at 4 °C. The supernatant was moved into a

new tube and used as cell extract for western blot analysis.

2.7.4 For mammalian cell lines immunoprecipitation experiment

The lysates for immnoprecipitation were prepared according to the description

in previous study 99. Briefly, cells were collected and washed twice with PBS buffer.

Then, the cell pellet was resuspended by appropriate volume of NET buffer [50 mM

Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.1% Triton X-100 and 1X protease

(55)

inhibitor (Roche, #11697498001)], usually 0.5 mL is sufficient for the cells collected

from a 10 cm dish, and incubated on ice for 30 minutes. Following that, centrifugation

was performed at 13200 rpm for 10 minutes at 4 °C. The supernatant was transferred to

a new tube and served as cell lysate for immunoprecipitation.

2.8 Western blot analysis

20-50 µg total proteins were used and mixed with 5X SDS sampling buffer

(375 mM Tris-HCl pH6.8, 10% SDS, 50% glycerol, 10% 2-mercaptoethanol and 0.03%

Bromo Blue) and then heat at 95 °C for 5 minutes to denature proteins. Following

centrifugation at 13200 for 30 second, the samples were then separated by 10% Bis-Tris

polyacrylamide gels and transferred to PVDF membranes for western blotting analysis.

In this thesis, antibodies and their working condition used for western blot were listed in

the table below.

Antibody against

Secondary antibody

Dilution/blocking reagent

Source

C. elegans

ALG-1 Rabbit 1:5000/ 5% Milk Thermo Fisher, PA1-031X PASH-1 Rabbit 1:1000/ 5% Milk From Dr. Helge Grosshan DDX-17 Rabbit 1:3000/ 5% Milk Home made by LTK Cop.

DDX-23 Rabbit 1:1000/ 3% BSA Home made by LTK Cop.

ACTIN Mouse 1:5000/ 5% Milk Proteintech, 66009-1-Ig

(56)

HRP-2 Rabbit 1:5000/ 5% Milk From Dr. Alan M. Zahler Mammalian cell lines

TRIM71 Sheep 1:3000/ 3% BSA R&D systems, AF5104 hnRNP Q/R Mouse 1:3000/ 5% Milk Sigma, R5653

ACTIN Mouse 1:10000/ 5%

Milk

Proteintech, 66009-1-Ig Ago2 Rabbit 1:5000/ 5% Milk Abcam, ab186733 HA-tag Mouse 1:1000/ 5% Milk Covance, MMS101R GFP-tag Mouse 1:1000/ 5% Milk Clontech, 632375

PABP Mouse 1:1000/ 5% Milk Santa Cruz, sc-32318

2.9 Co-immunoprecipitation

Immunoprecipitations were initiated by binding 1-2 µg antibody to Protein A

Sepharose beads (GE healthcare, #17-0780-01) in TBST buffer for 30 minutes at room

temperature. In this thesis, the antibodies used for IP experiments are anti-HRP-2,

anti-ALG-1 and anti-HA (3F10). It was subsequently washed twice by IP buffer and

supplemented with 500-1000 µg lysate into each reaction. For RNase treatment, 20 µg

RNase A (QIAGEN, #19101) was added into lysate and incubated at room temperature

for 20 minutes to digest total RNAs. Following incubation at 4 °C for at least 2 hours,

beads were washed by IP buffer five times and the precipitated proteins were eluted by

boiling in SDS sampling buffer. The samples were then centrifuged 5 min at 13200 rpm

to separate Protein A beads, and the supernatants were loaded into 10% Bis-Tris gel.

(57)

proteins.

2.10 RNA-immunoprecipitation (RIP)

The first step in RIP experiments was performed as the condition mentioned

above in IP experiment. After that, the pellet was subjected into RNA purification step

by adding 1 mL Genezol (Geneaid, #GZR100) for each reaction. Following addition of

200 µL chloroform and vigorously shaking the tube, the mixture was centrifuged at

12000 g for 15 minutes at 4 °C. The supernatant was moved into a new tube then mixed

with equal volume of isopropanol and 20 mg glycogen to let the pellet could be seen in

the following centrifugation step. After 10 minutes incubation at room temperature, it

was centrifuged at 12000 g for 20 minute at 4 °C to precipitate RNAs. The supernatant

was removed and the pellet was washed by 70% ethanol once at 13200 rpm for 5

minutes at 4 °C. Finally, the pellet was air-dried and dissolved in appropriate volume of

nuclease free water. The purified RNA samples were then subjected into northern blot

or quantitative RT-PCR analysis.

2.11 In vitro transcription of biotinylated RNA oligo

To PCR amplify the T7 promoter fused DNA templates for in vitro

數據

Table 1. Using let-7(n2853) mutant to screen for hnRNP(s) involved in let-7/lin-41  pathway
Figure 4.  Mock RNAiA vbh-1(RNAi)C mog-4(RNAi)E ddx-23(RNAi)Bddx-17(RNAi)Dcgh-1(RNAi)F sacy-1(RNAi)G hmr-1::GFP hmr-1::GFPhmr-1::GFPhmr-1::GFPhmr-1::GFPhmr-1::GFPhmr-1::GFP
Figure 5.  sacy-1(RNAi) cgh-1(RNAi) ddx-17(RNAi)ddx-23(RNAi)Mock RNAicol-19::GFPvbh-1(RNAi)mog-4(RNAi)ABDCEFG col-19::GFPcol-19::GFPcol-19::GFPcol-19::GFPcol-19::GFPcol-19::GFP
Figure 7.  Moc k  cgh-1 ddx-17  vbh-1 H27M09. 1 ddx-23  mog-4051015*****
+7

參考文獻

相關文件

„ 數個力所作的淨功 當兩力或更多的力作用在一物體 上,其所得之淨功(net work),就是這些力個別地 對此物體作功的總和。..

6 《中論·觀因緣品》,《佛藏要籍選刊》第 9 冊,上海古籍出版社 1994 年版,第 1

The first row shows the eyespot with white inner ring, black middle ring, and yellow outer ring in Bicyclus anynana.. The second row provides the eyespot with black inner ring

We would like to point out that unlike the pure potential case considered in [RW19], here, in order to guarantee the bulk decay of ˜u, we also need the boundary decay of ∇u due to

Wang, Solving pseudomonotone variational inequalities and pseudocon- vex optimization problems using the projection neural network, IEEE Transactions on Neural Networks 17

Hope theory: A member of the positive psychology family. Lopez (Eds.), Handbook of positive

Animal or vegetable fats and oils and their fractiors, boiled, oxidised, dehydrated, sulphurised, blown, polymerised by heat in vacuum or in inert gas or otherwise chemically

Milk and cream, in powder, granule or other solid form, of a fat content, by weight, exceeding 1.5%, not containing added sugar or other sweetening matter.